Data Intake & PHI Screening
DICOM/pathology data ingested via encrypted transfer; automated PHI detection and de-identification using NER + regex pipelines before annotation begins.
DICOM annotation, pathology labeling, clinical NLP, and HIPAA-aligned workflows — with domain-trained annotators, full audit trail traceability, and regulatory submission support.
DICOM/pathology data ingested via encrypted transfer; automated PHI detection and de-identification using NER + regex pipelines before annotation begins.
Domain-specific annotation guidelines co-authored with board-certified clinicians — covering anatomy definitions, severity grading scales, and edge-case protocols.
Annotators with medical imaging training assigned; credentialed reviewers (radiologists, pathologists) for L2/L3 QA.
L1 annotators label structures (segmentation, classification); L2 medical QA reviewers validate clinical accuracy; L3 board-certified expert adjudicates disagreements.
Dice coefficient ≥ 0.90 for segmentation, Cohen's κ ≥ 0.80 for classification enforced via gold-set benchmarking and periodic IAA audits.
Labeled datasets delivered with full provenance: annotator credentials, guideline version, timestamps, and audit trail formatted for FDA 510(k) / CE MDR submission packages.
Generic annotation vendors can label data. Domain experts label it correctly. Here's why the difference matters in your industry.
A misplaced segmentation boundary on a tumor can lead to incorrect radiation dosing. Our annotators are trained on anatomy-specific protocols and validated by board-certified clinicians — achieving Dice scores ≥ 0.90 vs. the industry average of 0.78.
FDA 510(k) and CE MDR submissions require documented evidence of data quality. Our annotation pipeline produces credential-linked audit trails, guideline version histories, and inter-annotator agreement reports — the documentation reviewers expect.
Medical data contains protected health information governed by HIPAA. Our pipeline includes automated PHI detection, secure annotation environments, and Business Associate Agreements — ensuring compliance isn't an afterthought.
See how our domain-specific capabilities compare to generic annotation services.
| Capability | UTL Data Engine | Typical Vendor |
|---|---|---|
| Board-certified clinical reviewers (radiologists, pathologists) | Verified credentials | General crowd |
| HIPAA-aligned data handling with BAA | Full BAA support | Varies |
| PHI de-identification before annotation | Automated + manual | Manual only |
| Dice coefficient ≥ 0.90 for segmentation QA | Enforced | Not measured |
| FDA/CE audit trail documentation | Included | Not available |
| Multi-specialty coverage (15+ specialties) | 2–3 specialties |
"UTL's medical annotation team delivered radiologist-level accuracy with full HIPAA compliance. The audit trails were critical for our FDA submission preparation."
Let's discuss your specific data challenges and build a tailored annotation pipeline.